Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.

Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin, according to a study ...

Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...

A larger percentage of patients in PFA group had treatment success at 12 months compared with those receiving antiarrhythmic-drug therapy.

About one-quarter of large outbreak-related cases ID'd through contact tracing; they less often had clinical markers of highly infectious disease ...

Vaccinations administered alone or sequentially are safe and effective, providing high RSV-A, -B nAb titers in infants ...

The approval is supported by bioequivalence data assessing the once-daily extended-release formulation to twice-daily immediate-release ruxolitinib in healthy participants.

Clinical data from a 16-patient pediatric study demonstrate the safety and efficacy of Asceniv in younger populations, ...

AASM recommends against use of combination of CBT-I plus medication over CBT-I alone for chronic insomnia disorder.

Nereus ™ (tradipitant) is now available for the prevention of vomiting induced by motion in adults. According to manufacturer Vanda Pharmaceuticals, the product is available by ...

Despite earlier antibiotic exposure being more common in those with celiac disease, researcher says 'the connections are much more complex' ...

Patients treated with dilanubicel demonstrated faster hematopoietic recovery and had a markedly lower incidence of severe acute GVHD. HealthDay News — Adding dilanubicel, a cryopreserved, cord blood ...